Analyst Conference Summaries

Biotechnology Investor Aids

Aprea Therapeutics

conference date: August 11, 2020 (press release only)

Aprea Therapeutics Cancer Therapy Platform Is Promising [July 21, 2020 at Seeking Alpha]

Q1 2020 release
Q2 2020 release
May 15, 2020 Aug. 11, 2020    

Aprea Therapeutics (APRE) is a clinical-stage biotechnology company specializing in therapies for cancers with TP53 mutations.

Aprea Therapeutics web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2020 William P. Meyers